|
|
||||||||
Leiden University Medical Center, Department of Pulmonology, Leiden, The Netherlands
Correspondence and requests for reprints should be addressed to Prof. Dr. K.F. Rabe, M.D., Ph.D., Department of Pulmonology, C3-P16, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. E-mail: k.f.rabe{at}lumc.nl
ABSTRACT
Chronic obstructive pulmonary disease (COPD) is a common disease with a global impact in terms of morbidity and mortality. Patients usually consult their doctor because of symptoms, and among those, dyspnea at rest or under exercise is one of the most common. The sensation of dyspnea is experienced differently among individuals with COPD and may be based on diverse factors, such as muscle fatigue, patient perception, or trapped volumes. Treatment algorithms for COPD emphasize a stepwise approach to therapy depending on the severity of the disease, which, for reasons of convenience, is primarily based on spirometric impairment. Drugs that alter bronchial smooth muscle tone and increase inspiratory capacity have clinical efficacy for the dyspneic patient, most likely based on their effect on lung function, whereas the effects of antiinflammatory therapy with inhaled corticosteroids is more difficult to explain. The following short review aims to give an overview of the available clinical information of clinical trials performed over the last couple of years.
Key Words: chronic respiratory disease, outcomes chronic respiratory disease, pharmacotherapy
This article has been cited by other articles:
![]() |
M. I.M. Versteegh, J. Braun, P. G. Voigt, D. B. Bosman, J. Stolk, K. F. Rabe, and R. A.E. Dion Diaphragm plication in adult patients with diaphragm paralysis leads to long-term improvement of pulmonary function and level of dyspnea Eur. J. Cardiothorac. Surg., September 1, 2007; 32(3): 449 - 456. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |